NCT01386281View on ClinicalTrials.gov

Julina Post-marketing Surveillance for Climacteric Symptoms in Japan

CompletedOBSERVATIONAL

Enrollment

506

Participants

Timeline

Start Date

October 20, 2008

Primary Completion Date

April 15, 2014

Study Completion Date

April 15, 2014

Conditions

Osteoporosis, Postmenopausal

Interventions

DRUG

E2 transdermal (Julina, BAY86-5435)

Patients in daily life treatment receiving Julina for postmenopausal osteoporosis

Trial Locations (1)

Unknown

Multiple Locations

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY